Cite
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
MLA
E Liu, et al. “Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.” Immunity, vol. 50, Feb. 2019, p. 477–492.e8. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....873c868785fb617149aa8148605a0083&authtype=sso&custid=ns315887.
APA
E Liu, Gillian A. Kinsbury, Katsunobu Hagihara, Adil Daud, Amy Jo Casbon, Marcella Fasso, Michel DuPage, Katy K. Tsai, Ravi Sachidanandam, Xiaoqing Lu, Kole T. Roybal, Li Zhang, Ingrid Lin, Jane Seagal, David Y. Oh, Mingyi Chen, Chanhyuk Park, Xiao X. Wei, Anitha D. Jayaprakash, … Clint Wu. (2019). Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade. Immunity, 50, 477–492.e8.
Chicago
E Liu, Gillian A. Kinsbury, Katsunobu Hagihara, Adil Daud, Amy Jo Casbon, Marcella Fasso, Michel DuPage, et al. 2019. “Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.” Immunity 50 (February): 477–492.e8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....873c868785fb617149aa8148605a0083&authtype=sso&custid=ns315887.